A Bayesian adaptive digital twin design for avatar-driven cancer clinical trials
Biometrics · 2026
DOI: 10.1093/biomtc/ujag165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, 2026. Verfasst von Peng Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, Rice University, Houston, TX 77005, United States. Hauptthemen laut MEDLINE: Avatar, Precision Medicine, Neoplasms, Clinical Trials as Topic. Die Arbeit nennt 37 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
The premise of personalized medicine is that patients exhibit significant heterogeneity and respond differently to treatments. The best treatment for one patient may not be suitable for another. In this paper, we propose a Bayesian adaptive design for an avatar-driven clinical trial, using mouse or laboratory animal grafts to create personalized tumor models that guide individualized patient treatment while accounting for translational discrepancy between avatars and patients. We jointly model the tumor growth of avatars and the clinical outcomes of patients, including toxicity and progression-free survival, to capture the interplay between avatars and their source patients. This joint model enables us to leverage both avatar treatment responses and patient data to predict the treatment utility for each patient and inform the selection of personalized optimal treatments, thereby serving as a digital twin of the patient. To address the fact that avatars may only serve as valid surrogates for treatment effects in a subset of patients, we incorporate a latent-class model that accounts for this translational discrepancy. Through simulation studies, we demonstrate that the proposed design outperforms conventional clinical trials lacking avatar information. Under this design, patients are significantly more likely to receive personalized optimal treatments, leading to improved treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Statistics, Rice University, Houston, TX 77005, United States.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
- Department of Statistics, Sungkyunkwan University, Jongno-gu, Seoul 03063, Korea.
ORCID-Profile: Peng Yang, Yeonhee Park, Suyu Liu
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Yang, P., Park, Y., & Liu, S. (2026). A Bayesian adaptive digital twin design for avatar-driven cancer clinical trials. Biometrics. https://doi.org/10.1093/biomtc/ujag165
Vancouver
Yang P, Park Y, Liu S. A Bayesian adaptive digital twin design for avatar-driven cancer clinical trials. Biometrics. 2026. doi:10.1093/biomtc/ujag165
BibTeX
@article{Yang2026,
author = {Yang, Peng and Park, Yeonhee and Liu, Suyu},
title = {A Bayesian adaptive digital twin design for avatar-driven cancer clinical trials},
journal = {Biometrics},
year = {2026},
doi = {10.1093/biomtc/ujag165}
}
EUVIMED